author-photo

José Fernandes

Curie Institute

15

Papers

324

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

A Difficult Diagnosis of a Myelodysplastic Syndrome/Myeloproliferative Neoplasm in its Limiting form and Interest of Next Generation Sequencing

2018
Show All
- Source
- Cite
- Save
Citations (0)
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy. Prospective Observational Study from the Acute Leukemia French Association (ALFA) Group

2016 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine

2016 Leukemia
Show All
- Source
- Cite
- Save
Citations (12)
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL

2016 Blood
Show All
- Source
- Cite
- Save
Citations (143)
Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7)

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Epidemiology of Adults AML in Nord-Pas De Calais and Picardy

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA)

2014 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study

2012 Blood
Show All
- Source
- Cite
- Save
Citations (23)
Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

2010 Blood
Show All
- Source
- Cite
- Save
Citations (30)